Literature DB >> 30305121

Epidemiology of subsequent bloodstream infections in the ICU.

Niccolò Buetti1, Elia Lo Priore2, Rami Sommerstein2, Andrew Atkinson2, Andreas Kronenberg3, Jonas Marschall2.   

Abstract

Subsequent bloodstream infections (sBSI) occur with a delay after removal of the intravascular catheter (IVC) whose tip revealed microbial growth. Here we describe the epidemiology of sBSI in the intensive care setting. Serratia marcescens, Staphylococcus aureus, Pseudomonas aeruginosa, and yeast were the pathogens most frequently associated with sBSI. In contrast, Enterococci were rarely found in sBSI.

Entities:  

Mesh:

Year:  2018        PMID: 30305121      PMCID: PMC6180638          DOI: 10.1186/s13054-018-2148-0

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


Letter

A recently published review on the management of catheter-related infection highlighted the clinical importance of a positive catheter culture without concomitant positive blood cultures in the ICU [1]. Recently, we conducted a nationwide, observational study on all positive intravascular catheter (IVC) tip cultures in Switzerland investigating subsequent bloodstream infections (i.e., bloodstream infection occurring after the catheter has been removed) with non-ICU and ICU data [2]. Interestingly, the studies investigating this topic reported either data from an individual hospital [1] or focused on single pathogens [3, 4]. Moreover, only one observational study studied the ICU population [5]. Based on the Swiss Antibiotic Resistance Surveillance System (ANRESIS), we aimed to describe the current epidemiology of culture-positive IVC tips without concurrent bacteremia in the ICU and to characterize bacteremia or fungemia occurring after catheter removal. We conducted a nationwide surveillance study on all positive IVC tip cultures recovered in Swiss ICUs (36 hospitals) from 2008 to 2015. An IVC tip culture, which required IVC removal, was included in the analysis if at least one microorganism could be cultivated. We excluded data from patients with concurrent bacteremia and fungemia with the same microorganism identified 7 days before to 2 days after IVC removal (623 cases). Subsequent bloodstream infection (sBSI) was defined as isolating (from blood cultures performed > 2 days up to 7 days after IVC removal) the same microorganism as the one recovered from the IVC tip. Over the 8-year period, 2,941 positive IVC tip cultures without concurrent bacteremia were identified in ICUs. In 3.1% (92/2,941, 95% confidence interval 2.5–3.8) of removed catheters an sBSI was observed (Fig. 1). Among bacterial microorganisms, Serratia marcescens (4/40, 10%, 3.3–24), Staphylococcus aureus (7/88, 8.0%, 3.5–16.2) and Pseudomonas aeruginosa (4/81, 4.9%, 1.6–12.8) were the most frequently identified agents causing sBSI. Subsequent fungemia developed in 8/29 (27.6%, 11.3–43.9) IVC tips positive for fungi (Additional file 1: Table S1). Enterococci rarely caused sBSI (1.6%, 0.5–4.2).
Fig. 1

Proportion and confidence intervals of subsequent bloodstream infections (sBSI) in the ICU

Proportion and confidence intervals of subsequent bloodstream infections (sBSI) in the ICU To our knowledge, ours is the largest epidemiologic description of sBSI in this setting. Our findings highlight that particular attention should be paid if Candida albicans, S. aureus, S. marcescens, and P. aeruginosa are detected on an IVC tip. The presence of these four microorganisms is associated with a higher frequency of sBSI than other microorganisms and, therefore, a short treatment may need to be considered by intensive care physicians. In contrast, enterococci represented the lowest risk for sBSI and probably do not require specific antimicrobial therapy. Table S1. Microorganism distribution of positive catheter tip culture and sBSI in the ICU. (DOCX 16 kb)
  5 in total

Review 1.  Preventing Staphylococcus aureus bacteremia and sepsis in patients with Staphylococcus aureus colonization of intravascular catheters: a retrospective multicenter study and meta-analysis.

Authors:  David J Hetem; Susanne C de Ruiter; Anton G M Buiting; Jan A J W Kluytmans; Steven F Thijsen; Bart J M Vlaminckx; Robert G F Wintermans; Marc J M Bonten; Miquel B Ekkelenkamp
Journal:  Medicine (Baltimore)       Date:  2011-07       Impact factor: 1.889

2.  Bloodstream infection after positive catheter cultures: what are the risks in the intensive care unit when catheters are routinely cultured on removal?

Authors:  Natacha Mrozek; Alexandre Lautrette; Claire Aumeran; Henri Laurichesse; Christiane Forestier; Ousmane Traoré; Bertrand Souweine
Journal:  Crit Care Med       Date:  2011-06       Impact factor: 7.598

Review 3.  A state of the art review on optimal practices to prevent, recognize, and manage complications associated with intravascular devices in the critically ill.

Authors:  Jean-François Timsit; Mark Rupp; Emilio Bouza; Vineet Chopra; Tarja Kärpänen; Kevin Laupland; Thiago Lisboa; Leonard Mermel; Olivier Mimoz; Jean-Jacques Parienti; Garyphalia Poulakou; Bertrand Souweine; Walter Zingg
Journal:  Intensive Care Med       Date:  2018-05-12       Impact factor: 17.440

4.  Is Candida colonization of central vascular catheters in non-candidemic, non-neutropenic patients an indication for antifungals?

Authors:  Alfonso Pérez-Parra; Patricia Muñoz; Jesús Guinea; Pablo Martín-Rabadán; María Guembe; Emilio Bouza
Journal:  Intensive Care Med       Date:  2009-02-11       Impact factor: 17.440

5.  Low incidence of subsequent bacteraemia or fungaemia after removal of a colonized intravascular catheter tip.

Authors:  N Buetti; E Lo Priore; A Atkinson; A Kronenberg; J Marschall
Journal:  Clin Microbiol Infect       Date:  2017-09-28       Impact factor: 8.067

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.